estradiol sans ordonnance propecia pas cher achat clomid en ligne zyprexa mg baclofen vente effexor sur le comptoir plavix et generique acheter furosemide online
  • viagra fast shipping advair-diskus drugstore cost anaheim clomid for sale enrofloxacin baytril ciprofloxacin and trimethoprim sulfa advair-diskus discount coupon printable georgia sex and the city viagra overnight delivery zithromax medication
  • preiswert cialis acquistare cialis su internet indien viagra cialis mg le moins cher cialis generico con paypal kamagra 100
  • synthroid side affect cialis overnight revia pills cheapest drugstore spironolactone where can i buy cialis mg generic propecia
    mestinon comprar online arcoxia sin receta
    prezzo cialis venta de cialis viagra sans ordonnances
    où acheter viagra france 
    acquisto levitra 
    viagra online 

    Oral temperature changes in head and neck cancer patients predicts side effect severity

    Thu, Jan 26, 2012

    Oral Cancer News

    Source: American Society for Radiation Oncology

    The abstract, “Pilot study of functional infrared imaging for early  detection of mucositis in locally advanced head and neck cancer  reated with chemoradiotherapy,” will be presented at the Head and  neck Society Meeting in Arizona today. This is a synopsis of that  presentation.

    Slight temperature increases of the oral mucus membranes early in a head and neck cancer patient’s chemotherapy and radiation therapy (chemoradiotherapy) treatment is a predictor of severe mucositis later in treatment, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

    Mucositis, or mouth sores, is a common side effect of chemoradiotherapy for head and neck cancer that is painful and can be very severe. Physicians cannot predict which patients will have mild mucositis or severe mucositis that would require narcotic pain  medication, nutritional support and/or feeding tubes.

    Researchers in this study hypothesized that using sensitive thermal imaging technology to measure temperature changes of less than  one-tenth of a degree early in treatment could predict the severity of mucositis later in treatment. This knowledge could allow for early  intervention and potential changes in therapy using a technology that is simple, harmless and non-invasive.

    Patients receiving chemoradiotherapy underwent baseline and weekly thermal imaging of their oral mucus membranes. All patients displayed an increase in temperature and severe mucositis was found in 53 percent of patients.

    “If we could predict which patients were going to suffer the greatest toxicity, we could proactively make changes to their care that could  ameliorate or prevent side effects,” Ezra Cohen, MD, lead author of the study and co-director of the head and neck cancer program at The  University of Chicago in Chicago, said. “Ultimately, we could identify the patients at higher risk of severe complications from treatment.”

    This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

    Print Friendly
    Be Sociable, Share!
    , , , , ,

    Leave a Reply

    You must be logged in to post a comment.